BEROTEC — Why was Berotec discontinued? — What medications replace Berotec?

Reading time: 12 min
WhatsApp ↗
Medical Encyclopedia · Allergy and Clinical Immunology

BEROTEC — Why was Berotec discontinued? — What medications replace Berotec?

Clinical Summary and Overview

When symptoms or doubts arise involving BEROTECDistinguishing between scientifically validated information and palliative care makes all the difference in the evolution of respiratory, skin, and systemic health. This page aims to deepen understanding of... "BEROTEC — Why was Berotec discontinued? — What medications replace Berotec?", providing clear context on how the immune system reacts, which signs require medical attention, and how to structure individualized and effective care.

Complementary Audiovisual Content: Click here to watch the full explanatory video on the official Brasil Sem Alergia YouTube channel..

✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project

Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.

BEROTEC — Why was Berotec discontinued? — What medications replace Berotec?

Understanding the Discontinuation of Berotec and Treatment Options for Respiratory Diseases

Fenoterol, widely known by the trade name Berotec, was a short-acting bronchodilator medication that saved many lives over the years, acting promptly in relieving acute respiratory crises. However, its frequent and prolonged use was observed to be associated with an increased risk of cardiovascular complications, such as cardiac arrhythmias and episodes of ventricular fibrillation. Due to this safety profile, current medical practice prefers to direct patients to other types of bronchodilators and safer, more modern therapeutic approaches.

To determine the best alternative treatment, a thorough medical evaluation is essential, including tests such as spirometry (pulmonary function test). This test allows the specialist to identify whether the patient presents with a purely obstructive condition—common in asthma—a restrictive pattern, or an overlap of conditions such as the association of asthma and pulmonary emphysema. Depending on the functional and clinical findings, the treatment needs to be more robust to adequately control inflammation and airway obstruction.

Currently, medicine offers advanced therapies for the control of chronic respiratory diseases, such as triple inhalation therapy. This therapeutic modality combines substances with different mechanisms of action:

  • Long-acting bronchodilators: Substances such as vilanterol, which help improve lung capacity and open the bronchi;
  • Anticholinergics: Like tiotropium, which acts to reduce the inflammatory process and decrease the excessive production of mucus;
  • Inhaled corticosteroids: Such as fluticasone furoate, potent local anti-inflammatory drugs that control chronic airway inflammation.

The indication for these advanced therapies follows rigorous international protocols, such as the GINA protocol (Global Initiative for AsthmaThis classification assesses the patient according to the severity of the disease and guides the most appropriate long-term maintenance treatment. Furthermore, it is important to emphasize that treatment of the lower airways should always consider associated conditions. Rhinitis, rhinosinusitis, and gastroesophageal reflux disease (acid or basic) frequently affect respiratory control, and their irritation can directly impact the lungs and worsen symptoms.

This content is strictly educational and informative in nature and should in no way replace consultation, diagnosis, and individualized evaluation with a specialist physician.

Developments in Evidence-Based Medicine: Pharmacokinetics and Safety of Corticosteroids

The consolidated guidelines of Evidence-Based Medicine (GINA, ARIA, and Allergy and Endocrinology consensus) establish a strict distinction between the... topical/inhaled corticosteroids — which act locally on the respiratory or cutaneous mucosa with minimal systemic bioavailability and constitute the safe basis for chronic anti-inflammatory control — and the Systemic corticosteroids (oral or injectable depot corticosteroids, such as the combination of betamethasone dipropionate and disodium phosphate)Injectable depot formulations maintain prolonged release for weeks, promoting suppression of the hypothalamic-pituitary-adrenal axis (risk of secondary adrenal insufficiency), hyperglycemia, hypertension, fluid retention, bone demineralization, subcapsular cataracts, and immunosuppression, and should not be used as maintenance therapy for rhinitis, asthma, or urticaria.

💎 Diamond Plan — Well-controlled asthma shouldn't require frequent trips to the emergency room. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Control of Bronchial Inflammation, Lung Function, and Prevention of Remodeling

Lower Airway Hyperreactivity and the Role of Inhalation Therapy

Bronchial asthma and allergic bronchitis are chronic inflammatory diseases of the lower airways, characterized by bronchial hyperreactivity, mucosal edema, mucus hypersecretion, and variable obstruction to expiratory airflow. When eosinophilic or allergic inflammation (type 2) remains uncontrolled over the years—or when the patient uses only short-term bronchodilators without treating the underlying inflammation—thickening of the basement membrane and hypertrophy of the bronchial smooth muscle occur, a process known as bronchial remodeling.

Inhalation Technique, Environmental Control and Respiratory Immunotherapy

The integration between environmental control of household dust, adherence to the prescribed preventive plan, and implementation of allergy test allows you to customize the asthma treatmentIn the presence of proven IgE sensitization, the asthma vaccine It acts on the immunological cause of respiratory hyper-reactivity, while cases of severe refractory asthma now have access to highly precise immunobiological drugs.

Immediate Reactions, Delayed Drug Reactions, and Risks of Self-Medication

Another critical pharmacovigilance point concerns the indiscriminate use of long-acting oral or injectable systemic corticosteroids (such as intramuscular betamethasone combinations). Although they provide apparent rapid relief, repeated applications suppress the hypothalamic-pituitary-adrenal axis, raise blood pressure and blood glucose, demineralize bone mass, weaken immunity against infections, and can cause local neuropathic pain when improperly applied to the gluteal region.

Epithelial Barrier, Eosinophilic Inflammation, and Intestinal Permeability

Immune-mediated disorders of the gastrointestinal tract—including eosinophilic esophagitis, celiac disease, and non-celiac gluten sensitivity—share alterations in the integrity of the tight junctions of the digestive epithelium. In eosinophilic esophagitis, frequently associated with rhinitis, asthma, and atopic dermatitis, eosinophil infiltration of the esophageal wall causes dysphagia, food impaction, and symptoms that mimic gastroesophageal reflux refractory to proton pump inhibitors.

Inflammation of the Respiratory Mucosa, House Mites, and Local Complications

Under the medical concept of a 'single airway', uncontrolled inflammation of the nasal cavities and paranasal sinuses directly impacts the ears (Eustachian tube dysfunction), eyes (rhinoconjunctivitis), sleep quality, and bronchi. In specific subgroups, such as Aspirin-Exacerbated Respiratory Disease (AERD), recurrent nasal polyposis, asthma, and intolerance to COX-1 inhibitor anti-inflammatory drugs are also present, requiring specialized diagnosis to restore the sense of smell and respiratory patency.

Clinical Safety Criteria and Warning Signs in Allergology

Early recognition of warning signs requiring priority medical reassessment is part of the health education of every patient and their family. Symptoms such as progressive dyspnea (difficulty breathing or speaking in complete sentences), refractory wheezing, sudden edema of the lips, tongue, or glottis, dizziness due to a drop in blood pressure, persistent fever associated with skin lesions or mucous membrane involvement require immediate emergency care, followed by a structured allergy investigation to prevent future recurrences.

Impact on Quality of Life, Sleep, and Systemic Well-being

Beyond the direct physical manifestations, uncontrolled conditions linked to BEROTEC profoundly interfere with restorative sleep patterns, concentration at school and work, and emotional balance. Chronic stress, through neuroendocrine mediators and epithelial alarmins, feeds back into the immune inflammatory response. Therefore, instituting a comprehensive approach to clinical and environmental rehabilitation restores daily autonomy and overall well-being to the individual.

Diamond Plan: Specialized Allergy Treatment Wherever You Are

SIGNATURE
DIAMOND

Allergy-Free Brazil

THE FUTURE OF TREATMENT

💎

  • Allergy and immunostimulant vaccines included.
  • Easy access (upon request)
  • Nationwide coverage — all of Brazil

brasilsemalergia.online

Living hundreds of miles from an allergist or having to interrupt treatment because of the price of vaccines shouldn't be anyone's fate. With the Diamond PlanBrazil Without Allergies brings the same high standard of care from its clinics to your home, with telemedicine consultations and a more accessible path to immunotherapy. Well-controlled asthma shouldn't depend on frequent trips to the emergency room.

Why do patients across Brazil choose the Diamond Plan?

  • Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
  • easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
  • A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
  • Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
  • National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.

More than 30 years caring for people with allergies.

Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.

START TODAY

Your expert consultation is just a click away.

I want to join the Diamond Plan.Schedule a teleconsultation

Official telemedicine environment: brasilsemalergia.online

Do you prefer to be served in person?

Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:

Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.

The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Conclusion and Summary of Guidelines

In summary, the appropriate approach to BEROTEC It requires a clear understanding of the immunological mechanisms involved, precise etiological diagnosis, and individualized medical follow-up. Avoiding self-medication and investigating the root cause of symptoms—relying on specialized resources and reliable guidance such as specialized allergy and immunology care when clinically relevant—is the safest way to control flare-ups, prevent complications, and ensure sustainable quality of life.

Scientific references and authoritative sources

The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information: